Louisiana Administrative Code
Title 51 - PUBLIC HEALTH-SANITARY CODE
Part XXIX - Medical Marijuana
Chapter 7 - Inspections and Operational Requirements
Section XXIX-713 - Sampling Requirements
Current through Register Vol. 50, No. 9, September 20, 2024
A. Permittees shall sample every batch of product to ensure compliance with the standards of quality outlined below. Permittees shall not release any batch of product for sale until the representative sample has been verified as compliant. Batches may be tested prior to portioning or packaging.
B. Sample verification shall be by means of the issuance of a certificate of analysis from the approved laboratory conducting the sample analysis issued to the Louisiana Department of Health and the originating facility no later than 24 hours after testing is complete.
C. Any batch with a sample failing one or more of the tests (by exceeding allowable limits for contaminants or residues) shall be remediated or destroyed, at the option of the permittee. A batch shall only be remediated once, and if subsequent sampling fails to correct the exceedance, the affected batch shall be destroyed.
D. Sample medical marijuana waste held at an approved laboratory shall be destroyed within 60 days of completion of testing.
E. Minimally-processed plant material shall be subject to all testing requirements below except testing for solvent residues.
F. Medical marijuana samples shall be required to meet the following standards of quality:
G. Table 1. Category I and II Pesticide Residue Maximum Contaminant Levels (MCL) in parts per million (ppm) by dosage form
Name |
Ingested |
Inhaled |
Category I (includes aldicarb, carbofuran, chlorpyrifos, coumaphos, daminozide, dichlorvos, dimethoate, ethoprop(hos), etofenprox, fenoxycarb, imazalil, methocarb, methyl parathion, mevinphos, paclobutrazol, propoxur, spiroxamine, and thiacloprid) |
0 |
0 |
Category II |
||
Abamectin |
0.3 |
0.1 |
Acephate |
5 |
0.1 |
Acetamiprid |
5 |
0.1 |
Acequinocyl |
4 |
0.1 |
Azoxystrobin |
40 |
0.1 |
Bifenzate |
5 |
0.1 |
Bifenthrin |
0.5 |
3 |
Boscalid |
10 |
0.1 |
Captan |
5 |
0.7 |
Carbaryl |
0.5 |
0.5 |
Chlorantraniliprole |
40 |
10 |
Clofentezine |
0.5 |
0.1 |
Cyfluthrin |
1 |
2 |
Cypermethrin |
1 |
1 |
Diazinon |
0.2 |
0.1 |
Dimethomorph |
20 |
2 |
Etoxazole |
1.5 |
0.1 |
Fenhexamid |
10 |
0.1 |
Fenpyroximate |
2 |
0.1 |
Flonicamid |
2 |
0.1 |
Fludioxionil |
30 |
0.1 |
Hexythiazox |
2 |
0.1 |
Imidacloprid |
3 |
5 |
Kresoxim-methyl |
1 |
0.1 |
Malathion |
5 |
0.5 |
Metalaxyl |
15 |
2 |
Methomyl |
0.1 |
1 |
Myclobutanil |
9 |
0.1 |
Naled |
0.5 |
0.1 |
Oxamyl |
0.2 |
0.5 |
Pentachloronitrobenzene |
0.2 |
0.1 |
Permethrin |
20 |
0.5 |
Phosmet |
0.2 |
0.1 |
Piperonylbutoxide |
8 |
3 |
Prallethrin |
0.4 |
0.1 |
Propiconazole |
20 |
0.1 |
Pyrethrins |
1 |
0.5 |
Pyradiben |
3 |
0.1 |
Spinetoram |
3 |
0.1 |
Spinosad |
3 |
0.1 |
Spiromesifen |
12 |
0.1 |
Spirotetramat |
13 |
0.1 |
Tebuconazole |
2 |
0.1 |
Thiamethoxam |
4.5 |
5 |
Trifloxystrobin |
30 |
0.1 |
AUTHORITY NOTE: Promulgated in accordance with R.S. 40:1046 et seq.